Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001672726-16-000002
Filing Date
2016-12-19
Accepted
2016-12-19 11:53:54
Documents
1
Effectiveness Date
2016-12-19
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 6333
  Complete submission text file 0001672726-16-000002.txt   7364
Mailing Address 439 HELMCKEN STREET VANCOUVER A1 V6B 2E6
Business Address 439 HELMCKEN STREET VANCOUVER A1 V6B 2E6 604-671-6673
Medicenna Therapeutics Inc. (Filer) CIK: 0001672726 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0331
Type: D/A | Act: 33 | File No.: 021-261759 | Film No.: 162058280